Markus Eckstein is an Advanced Clinician Scientist at the IZKF, University Hospital Erlangen, Erlangen, Germany and a Resident at the Institute of Pathology, University Hospital Erlangen. He obtained his medical degree from the Medical School of the Friedrich-Alexander-Universität Erlangen-Nürnberg in 2014 followed by further training in Gynecology and Obstetrics, Visceral Surgery, and Cardiology and Internal Medicine from the University Hospital Erlangen. His doctoral thesis was titled “The effects of an overnight holding of whole blood at room temperature on hemoglobin modification and in vitro markers of red blood cell aging.”
Dr Eckstein is an Associate Member of the Patient Information and Advocacy Group of the European Society of Urology (EAU-PI), an Associate Member of the EAU Section of Uropathology (ESUP), and member of the European Society of Urology (EAU), International Bladder Cancer Network (IBCN), the German Society of Pathology, the German Society for Immune and Targeted Therapy, and the BRIDGE Consortium Germany. He is the Principal Investigator of several clinical trials and real-word evidence studies in bladder and urothelial cancer. Dr Eckstein has authored more than 80 articles in many prestigious peer-reviewed journals, including in European Urology, Journal for Immunotherapy of Cancer, Cancer Research, Cancer Immunology Research, Cancers, Cells, Scientific Reports and Frontiers in Oncology. He has won several awards at various congresses and conferences, including the “Best Paper Award on Fundamental Research of the EAU in 2021” and the “Urologia Internationalis award” of the German Association of Urology, twice in 2017 and 2019.
EM-73545 - Date of Preparation: September 2021